{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-006531","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.708443+00:00","generated_at":"2026-05-22T11:01:34.441135+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CytoDyn appoints Robert E. Hoffman as CFO effective May 15, 2025","bullets":["Hoffman replaces interim CFO Mitch Cohen; Cohen resigns effective May 12 with last day May 30.","Compensation includes $450,000 base salary, 40% target bonus, option for 1M shares, PSUs for 3.5M shares.","Hoffman has 30+ years biotech experience; previously CFO at Heron Therapeutics, AnaptysBio, and Arena Pharmaceuticals.","Hoffman currently serves on boards of Esperion Therapeutics, TuHURA Biosciences, and Fibrobiologics."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-006531","json":"https://secwatch.observer/filing/0001558370-25-006531.json","markdown":"https://secwatch.observer/filing/0001558370-25-006531.md","text":"https://secwatch.observer/filing/0001558370-25-006531.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000155837025006531/0001558370-25-006531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000155837025006531/cydy-20250502x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T11:01:34.441135+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"93d6cde4c3","claim":"Robert E. Hoffman was appointed as Chief Financial Officer at CytoDyn Inc..","evidence_excerpt":"On May 2, 2025, the Company entered into an agreement with Robert E. Hoffman (“Mr. Hoffman”), under which Mr. Hoffman will serve as the Company’s Chief Financial Officer (“CFO”), effective May 15, 2025 (the “Employment Agreement”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000155837025006531/0001558370-25-006531-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}